advanced search

EXPERT VIEW

NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY
EXPERT VIEW
Frédérique Bordes-Picard
NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY
Frédérique Bordes-Picard looks at the role of nanotechnology in the nasal and pulmonary routes of drug delivery and explains how nanoparticle explains how nanoparticle solutions could transform patient comfort and compliance.
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
EXPERT VIEW
Rob Udale
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.
DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?
EXPERT VIEW
Wilbur de Kruijf
DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?
Wilbur de Kruijf and Bernhard Müllinger discuss the the market requirements for new inhalation options and the benefits of soft mist inhalers.
USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY
EXPERT VIEW
Dr Justin Lacombe
USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY
Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.
AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS
EXPERT VIEW
Dr Caterina Minelli
AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS
Caterina Minelli discusses the importance of co-operation between metrology institutes and the pharmaceutical industry in the pursuit of improving analytical techniques and standards for the characterisation of particle attributes in drug development.
EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS
EXPERT VIEW
Daniel Lock
EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS
Daniel Lock discusses the latest innovations in nebuliser technology for drug delivery to the lungs.
CAPSULES FOR DRY POWDER INHALATION – A COMPLETE PRODUCT
EXPERT VIEW
Anita Solanki
CAPSULES FOR DRY POWDER INHALATION – A COMPLETE PRODUCT
Anita Solanki, Jnanadeva Bhat and Justin Kalafat discuss capsules for dry powder formulation and consider their potential as a dosage form for patients with respiratory conditions and systemic illnesses.
WHY GENE THERAPY IS PERFECT FOR TREATING OCULAR DISEASES
EXPERT VIEW
Dr Yongdong Zhou
WHY GENE THERAPY IS PERFECT FOR TREATING OCULAR DISEASES
Yongdong Zhou discusses the applications, advantages and challenges of gene therapy in the ophthalmic sector.
ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY
EXPERT VIEW
Dr Jay S Duker
ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY
Jay S Duker discusses the history and future of ocular drug delivery, with a special focus on posterior segment diseases and the battle to overcome significant patient and caregiver burdens.
KEEPING UP WITH THE DEMAND FOR EFFECTIVE OPHTHALMIC DRUGS
EXPERT VIEW
Robert Lee
KEEPING UP WITH THE DEMAND FOR EFFECTIVE OPHTHALMIC DRUGS
Robert Lee explores the growth of the ophthalmic drug market and discuss the challenges that pharma companies may face when creating drugs to treat some of the most common ocular indications.
A VIEW ON THE USE OF APROTIC SOLVENTS IN PARENTERAL DRUG FORMULATIONS
EXPERT VIEW
Michael Neely
A VIEW ON THE USE OF APROTIC SOLVENTS IN PARENTERAL DRUG FORMULATIONS
Michael Neely presents a review and discussion of the status of aprotic solvents as a solubilising vehicle for parenteral drug formulations in the context of the industry’s increasing interest in biologic drugs.
DRUG DELIVERY DEVICE TRENDS FOR 2022
EXPERT VIEW
Tom Oakley
DRUG DELIVERY DEVICE TRENDS FOR 2022
Tom Oakley looks at some of the current trends in the drug delivery industry and projects some of the key factors that will influence drug delivery decision making in 2022.
VOICE-ACTIVATED USER INTERFACES IN DRUG DELIVERY DEVICES CAN ENHANCE COMPLIANCE AND OUTCOMES
EXPERT VIEW
Salvatore Forte
VOICE-ACTIVATED USER INTERFACES IN DRUG DELIVERY DEVICES CAN ENHANCE COMPLIANCE AND OUTCOMES
Salvatore Forte looks at the evolution of voice-activated interfaces in medical devices, particularly autoinjectors, and the advantages for patient compliance and quality of care.
MDR COMPLIANCE: PLANNING FOR POST-MARKET CLINICAL FOLLOW-UP
EXPERT VIEW
Dr Celeste Maksim
MDR COMPLIANCE: PLANNING FOR POST-MARKET CLINICAL FOLLOW-UP
Celeste Maksim discusses best practices for drug delivery device manufacturers when conducting post-market clinical follow-up activities, as mandated by the EU Medical Device Regulation.
EVOLVING ANALYTICAL METHODS: ADVANCES IN MOLECULE CHARACTERISATION
EXPERT VIEW
Eliza Lee
EVOLVING ANALYTICAL METHODS: ADVANCES IN MOLECULE CHARACTERISATION
Eliza Lee discusses some of the modern analytical techniques available for the characterisation of modern biologics, and how CDMOs equipped with these techniques are able to support pharmaceutical development.
“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE
EXPERT VIEW
Natalie Shortt
“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE
Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.
ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY
EXPERT VIEW
Robert Lee
ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY
Robert Lee discusses the benefits of administering drugs to the nasal cavity, as well as the main challenges in formulation for this route and the strategies that can be applied to overcome them.
POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY
EXPERT VIEW
Dr Joana Pinto
POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY
Jamie Clayton, Joana Pinto and Sarah Zellnitz discuss the benefits of multi-faceted powder characterisation in dry powder inhalation formulations and how it can support efforts to achieve net zero emissions.
SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR
EXPERT VIEW
Cormac O'Prey
SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR
Cormac O’Prey discusses some of the sustainability challenges facing the medical sector, such as how to make re-use and remanufacturing viable for high-volume, low-value products, and how answers can be found by looking to successful solutions deployed by other industries.
PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021
EXPERT VIEW
PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021
Pharmapack presents the results of its annual survey and market report, covering the latest Pharmapack Innovation Index and the inaugural Pharmapack Sustainability Index, and taking stock of where the survey results suggest the pharma industry currently is, and where it is heading, in terms of innovation and sustainability.
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
EXPERT VIEW
Kay Sinclair
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
Kay Sinclair, Brennan Miles and Charlie Dean provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.
INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT
INTERVIEW
Mathias Romacker
INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT
In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.
USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN
EXPERT VIEW
Enrico Denna
USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN
Enrico Denna looks at the advantages of a simulation and modelling approach over prototyping for the design of medical products.
OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES
EXPERT VIEW
Tim Resker
OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES
Tim Resker looks at new technologies for powering on battery-operated drug delivery devices while considering battery drain, ingress protection and user-friendliness.
Top